RA: Rituximab Preferred After TNF Inhibitor Failure Medscape Patients with rheumatoid arthritis (RA) who have an inadequate response to a single TNF inhibitor (TNFi) generally do better if they switch to rituximab, rather than to an alternative TNF inhibitor, Paul Emery, MD, and colleagues report in an article ... |
